177932-89-7|XM 412|2H-1,3-Diazepin-2-one, 1,3-bis((3-aminophenyl)methyl)hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-, (4R,5S,6S,7R)-, dimethanesulfonate (salt)|-范德生物科技公司

XM 412

NMR下载 COA and HPLC MSDS下载
names：
2H-1,3-Diazepin-2-one, 1,3-bis((3-aminophenyl)methyl)hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-, (4R,5S,6S,7R)-, dimethanesulfonate (salt)
CAS号：
177932-89-7
MDL Number：
MF(分子式)： C35H44N4O9S2 MW(分子量)： 728.876
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	2H-1,3-Diazepin-2-one, 1,3-bis((3-aminophenyl)methyl)hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-, (4R,5S,6S,7R)-, dimethanesulfonate (salt)
英文别名	XM 412; DMP 450
CAS号	177932-89-7
Inchi	InChI=1S/C33H36N4O3.2CH4O3S/c34-27-15-7-13-25(17-27)21-36-29(19-23-9-3-1-4-10-23)31(38)32(39)30(20-24-11-5-2-6-12-24)37(33(36)40)22-26-14-8-16-28(35)18-26;21-5(2,3)4/h1-18,29-32,38-39H,19-22,34-35H2;21H3,(H,2,3,4)/t29-,30-,31+,32+;;/m1../s1
InchiKey	HINZVVDZPLARRP-YSVIXOAZSA-N
分子式 Formula	C35H44N4O9S2
分子量 Molecular Weight	728.876
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	XM 412(CAS:177932-89-7):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	XM 412, also known as DMP 450, is an HIV protease inhibitor.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Hodge CN, Aldrich PE, Bacheler LT, Chang CH, Eyermann CJ, Garber S, Grubb M, Jackson DA, Jadhav PK, Korant B, Lam PY, Maurin MB, Meek JL, Otto MJ, Rayner MM, Reid C, Sharpe TR, Shum L, Winslow DL, Erickson-Viitanen S. Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450. Chem Biol. 1996 Apr;3(4):301-14. PubMed PMID: 8807858.

[2]Hylton KG, Main AD, McElwee-White L. Catalytic carbonylation of functionalized diamines: application to the core structure of DMP 323 and DMP 450. J Org Chem. 2003 Feb 21;68(4):1615-7. PubMed PMID: 12585919.

[3] Grubb MF, Robinson CA, White SJ, Krauthauser CL, Shum L. Determination of a HIV protease inhibitor (DMP 450) in animal and human plasma by solid-phase extraction and high-performance liquid chromatography. J Chromatogr B Biomed Appl. 1996 Apr 12;678(2):303-8. PubMed PMID: 8738035.

[4] Ala PJ, Huston EE, Klabe RM, McCabe DD, Duke JL, Rizzo CJ, Korant BD, DeLoskey RJ, Lam PY, Hodge CN, Chang CH. Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors. Biochemistry. 1997 Feb 18;36(7):1573-80. Erratum in: Biochemistry 1997 May 27;36(21):6556. PubMed PMID: 9048541.

[5] Vickery RD, Maurin MB. Utility of microcalorimetry in the characterization of the browning reaction. J Pharm Biomed Anal. 1999 Jun;20(1-2):385-8. PubMed PMID: 10704046.

6: De Lucca GV, Jadhav PK, Waltermire RE, Aungst BJ, Erickson-Viitanen S, Lam PY. De novo design and discovery of cyclic HIV protease inhibitors capable of displacing the active-site structural water molecule. Pharm Biotechnol. 1998;11:257-84. Review. PubMed PMID: 9760684.7: Nugiel DA, Jacobs K, Kaltenbach RF, Worley T, Patel M, Meyer DT, Jadhav PK, De Lucca GV, Smyser TE, Klabe RM, Bacheler LT, Rayner MM, Seitz SP. Preparation and structure-activity relationship of novel P1/P1'-substituted cyclic urea-based human immunodeficiency virus type-1 protease inhibitors. J Med Chem. 1996 May 24;39(11):2156-69. PubMed PMID: 8667359.8: Patel M, Bacheler LT, Rayner MM, Cordova BC, Klabe RM, Erickson-Viitanen S, Seitz SP. The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residues. Bioorg Med Chem Lett. 1998 Apr 7;8(7):823-8. PubMed PMID: 9871548.9: Aungst BJ, Nguyen NH, Bulgarelli JP, Oates-Lenz K. The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds. Pharm Res. 2000 Oct;17(10):1175-80. PubMed PMID: 11145221.10: Rayner MM, Cordova B, Jackson DA. Population dynamics studies of wild-type and drug-resistant mutant HIV in mixed infections. Virology. 1997 Sep 15;236(1):85-94. PubMed PMID: 9299620.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开